The clinical utilization of ketone bodies—primarily beta-hydroxybutyrate (BHB) and acetoacetate—as an alternative and highly efficient energy substrate for the central nervous system, particularly when glucose metabolism is impaired or restricted. This metabolic state offers a neuroprotective advantage by providing a cleaner, more stable fuel source for neurons and glial cells. It is a therapeutic focus in metabolic and neurological health.
Origin
This concept stems from the classical understanding of human physiology during fasting or carbohydrate restriction, where the liver produces ketones from fatty acid oxidation. The term has been repurposed in a clinical context to highlight the deliberate induction of ketosis for therapeutic brain benefit. It links the metabolic state of ketosis directly to cognitive enhancement and neuroprotection.
Mechanism
Ketone bodies, unlike fatty acids, readily cross the blood-brain barrier via specific monocarboxylate transporters. Once inside the brain, BHB is converted to acetyl-CoA, entering the Krebs cycle to generate ATP with greater thermodynamic efficiency than glucose. Furthermore, BHB acts as a signaling molecule, inhibiting histone deacetylases (HDACs) to promote the expression of protective genes, including those involved in antioxidant defense and mitochondrial biogenesis.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.